Relevant bibliographies by topics / Unconventional therapies / Journal articles

Journal articles on the topic 'Unconventional therapies'

To see the other types of publications on this topic, follow the link: Unconventional therapies.
Author: Grafiati
Published: 4 June 2021
Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Unconventional therapies.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ernst, Edzard. "Unconventional Cancer Therapies." Chest 117, no. 2 (February 2000): 307–8. http://dx.doi.org/10.1378/chest.117.2.307.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Szelenyi, I., and K. Brune. "Unconventional therapies in asthma." Drugs of Today 37, no. 10 (2001): 651. http://dx.doi.org/10.1358/dot.2001.37.10.844212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Unconventional therapies have huge impact." Inpharma Weekly &NA;, no. 873 (February 1993): 7. http://dx.doi.org/10.2165/00128413-199308730-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fitch, Margaret I., Ross E. Gray, Marlene Greenberg, Manon Labrecque, and Mary Sue Douglas. "Nurses' perspectives on unconventional therapies." Cancer Nursing 22, no. 3 (June 1999): 238–45. http://dx.doi.org/10.1097/00002820-199906000-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gray, Ross E. "Four perspectives on unconventional therapies." Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 2, no. 1 (January 1998): 55–74. http://dx.doi.org/10.1177/136345939800200104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marasca, Claudio, Maria Carmela Annunziata, Maddalena Napolitano, and Gabriella Fabbrocini. "Unconventional therapies for hidradenitis suppurativa." Expert Review of Clinical Pharmacology 11, no. 9 (August 23, 2018): 879–87. http://dx.doi.org/10.1080/17512433.2018.1509706.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ponzoni, Maurilio, Andrés JM Ferreri, Claudio Doglioni, and Riccardo Dolcetti. "Unconventional therapies in ocular adnexal lymphomas." Expert Review of Anticancer Therapy 10, no. 9 (September 2010): 1341–43. http://dx.doi.org/10.1586/era.10.125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gray, Ross E., Margaret Fitch, Marlene Greenberg, Peter Voros, Mary S. Douglas, Manon Labrecque, and Pamela Chart. "Physician Perspectives on Unconventional Cancer Therapies." Journal of Palliative Care 13, no. 2 (June 1997): 14–21. http://dx.doi.org/10.1177/082585979701300204.

Full text
Abstract:
The popularity of unconventional therapies has grown dramatically in recent years. This paper reports on the results of a pilot study investigating the perspectives of physicians involved with cancer care regarding their reactions to this trend and their ways of trying to meet associated challenges. Nine oncologists, nine general practitioners, and one surgeon were interviewed over the telephone, employing open-ended questions. The physicians were unanimously interested in having information available about unconventional therapies. They also expressed a desire to be supportive of patient choices in this area, provided conventional therapy was not compromised. However, there was little interest in initiating communication about unconventional therapies, with most seeing such discussions as a poor use of their time. Suggestions for future research, as well as educational and policy strategies, are addressed.
APA, Harvard, Vancouver, ISO, and other styles
9

Lewith, G. T., and A. D. Watkins. "Unconventional therapies in asthma: an overview." Allergy 51, no. 11 (November 1996): 761–69. http://dx.doi.org/10.1111/j.1398-9995.1996.tb04464.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

MCNAMARA, DAMIAN. "Be Aware of Unconventional, Cultural Therapies." Pediatric News 42, no. 8 (August 2008): 46. http://dx.doi.org/10.1016/s0031-398x(08)70384-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Barzilai, D. "Conventional Medical Care and Unconventional Therapies." JAMA: The Journal of the American Medical Association 283, no. 1 (January 5, 2000): 56–57. http://dx.doi.org/10.1001/jama.283.1.56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Fitch, Margaret I., Ross E. Gray, Marlene Greenberg, Mary Sue Douglas, Manon Labrecque, Peggi Pavlin, Nancy Gabel, and Sandra Freedhoff. "Oncology nurses' perspectives on unconventional therapies." Cancer Nursing 22, no. 1 (February 1999): 90–96. http://dx.doi.org/10.1097/00002820-199902000-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Nelson, Harry. "USA: NIH approach to unconventional therapies." Lancet 340, no. 8811 (July 1992): 106–7. http://dx.doi.org/10.1016/0140-6736(92)90413-w.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Atanaskova Mesinkovska, Natasha. "Emerging Unconventional Therapies for Alopecia Areata." Journal of Investigative Dermatology Symposium Proceedings 19, no. 1 (January 2018): S32—S33. http://dx.doi.org/10.1016/j.jisp.2017.10.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Sastre-Garriga, Jaume, Elvira Munteis, Jordi Río, Imma Pericot, Mar Tintoré, and Xavier Montalban. "Unconventional therapy in multiple sclerosis." Multiple Sclerosis Journal 9, no. 3 (June 2003): 320–22. http://dx.doi.org/10.1191/1352458503ms913sr.

Full text
Abstract:
Background: The use of unconventional therapies is growing in western countries. Few studies on their frequency and rationale among multiple sclerosis (MS) patients have been carried out in Europe. Objective: To assess the frequency of use of unconventional therapies among MS patients and to explore associated clinical variables. Methods: Structured questionnaires were given to 380 consecutive patients seen at two hospital-based MS clinics in Barcelona. C linical and demographical data were recorded at the same time. The questionnaire inquired about demographical features, educatio n, income, use of unconventional therapies for MS and satisfaction with conventional medicine both in general and specifically in MS. Results: The response rate was 50.78%. Forty-one per cent of patients admitted using unconventional therapies during the previous year. Low levels of satisfaction with conventional medicine in general and for MS, and higher Expanded Disability Status Scale (EDSS) scores (EDSS mean: 4.43 in users versus 3.48 in nonusers) were significantly associated with use of unconventional therapies. Conclusion: Use of unconventional therapies is not rare among MS patients, and it is associated with high disability levels and dissatisfaction with conventional medicine.
APA, Harvard, Vancouver, ISO, and other styles
16

MCNAMARA, DAMIAN. "Awareness of Unconventional Therapies Aids Treatment Plan." Internal Medicine News 41, no. 10 (May 2008): 23. http://dx.doi.org/10.1016/s1097-8690(08)70575-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Couzin, J. "Beefed-Up NIH Center Probes Unconventional Therapies." Science 282, no. 5397 (December 18, 1998): 2175–76. http://dx.doi.org/10.1126/science.282.5397.2175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Ziporyn, Terra. "Rare hyper-, hypothyroid states require unconventional therapies." JAMA: The Journal of the American Medical Association 253, no. 6 (February 8, 1985): 737. http://dx.doi.org/10.1001/jama.1985.03350300015002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Holl, R. M. "A Comparison of Three Unconventional Cancer Therapies." Complementary Health Practice Review 3, no. 3 (October 1, 1997): 167–76. http://dx.doi.org/10.1177/153321019700300304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Münstedt, K., K. Kirsch, W. Milch, and H. Vahrson. "1223 Why patients seek unconventional cancer therapies." European Journal of Cancer 31 (November 1995): S256. http://dx.doi.org/10.1016/0959-8049(95)96469-t.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Ziporyn, T. "Rare hyper-, hypothyroid states require unconventional therapies." JAMA: The Journal of the American Medical Association 253, no. 6 (February 8, 1985): 737–39. http://dx.doi.org/10.1001/jama.253.6.737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Arcury, Thomas A., Wilbert M. Gesler, and Harold L. Cook. "Meaning in the Use of Unconventional Arthritis Therapies." American Journal of Health Promotion 14, no. 1 (September 1999): 7–15. http://dx.doi.org/10.4278/0890-1171-14.1.7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Vickers, Andrew J., and Barrie R. Cassileth. "Unconventional therapies for cancer and cancer-related symptoms." Lancet Oncology 2, no. 4 (April 2001): 226–32. http://dx.doi.org/10.1016/s1470-2045(00)00293-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Gupta, Dhiren, and Rohit Vohra. "Refractory status asthmaticus: A case for unconventional therapies." Indian Journal of Critical Care Medicine 22, no. 10 (2018): 749–52. http://dx.doi.org/10.4103/ijccm.ijccm_191_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Fintor, L. "OTA Report Disputes Success of Unconventional Cancer Therapies." JNCI Journal of the National Cancer Institute 82, no. 21 (November 7, 1990): 1668–69. http://dx.doi.org/10.1093/jnci/82.21.1668.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Gray, Ross E., Marlene Greenberg, Margaret Fitch, Natalie Parry, Mary S. Douglas, and Manon Labrecque. "Perspectives of Cancer Survivors Interested in Unconventional Therapies." Journal of Psychosocial Oncology 15, no. 3-4 (March 27, 1998): 149–71. http://dx.doi.org/10.1300/j077v15n03_07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Jarski, Robert W. "Commentary: Meaning in the Use of Unconventional Arthritis Therapies." American Journal of Health Promotion 14, no. 1 (September 1999): 16–17. http://dx.doi.org/10.4278/0890-1171-14.1.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

MCNAMARA, DAMIAN. "Ask About Use of Unconventional Therapies for Lung Disorders." Family Practice News 38, no. 10 (May 2008): 33. http://dx.doi.org/10.1016/s0300-7073(08)70671-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

&NA;. "Wonder If Patients Use Unconventional Therapies? Try Asking Them." Lippincott's Bone and Joint Newsletter 5, no. 10 (November 1999): 110. http://dx.doi.org/10.1097/01300517-199911000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Nayak, Sangeetha, Robert J. Matheis, Nancy E. Schoenberger, and Samuel C. Shiflett. "Use of unconventional therapies by individuals with multiple sclerosis." Clinical Rehabilitation 17, no. 2 (March 2003): 181–91. http://dx.doi.org/10.1191/0269215503cr604oa.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Spiegel, Wolfgang, Francesco Carelli, and Manfred Maier. "Unconventional therapies and general practice: Implications for academic medicine." European Journal of General Practice 13, no. 1 (January 2007): 3–4. http://dx.doi.org/10.1080/13814780701237683.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Münstedt, K., A. Entezami, R. von Georgi, S. Sachsse, M. Zygmunt, A. Wartenberg, and U. Kullmer. "Attidudes of physicians and oncologists towards unconventional cancer therapies (UCTs)." European Journal of Cancer 35 (September 1999): S277. http://dx.doi.org/10.1016/s0959-8049(99)81528-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Giannattasio, C., A. Maloberti, E. Piccinelli, J. Zanoni, S. Castelnuovo, P. Vallerio, I. Bassi, et al. "EFFECTS OF CHRONIC HEART FAILURE UNCONVENTIONAL THERAPIES ON ENDOTHELIAL FUNCTION." Journal of Hypertension 37 (July 2019): e71. http://dx.doi.org/10.1097/01.hjh.0000571068.93010.00.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Eidinger, R. N., and D. V. Schapira. "Cancer patientsʼ insight into their treatment, prognosis, and unconventional therapies." Plastic and Reconstructive Surgery 75, no. 4 (April 1985): 617. http://dx.doi.org/10.1097/00006534-198504000-00091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Druss, Benjamin G. "Association Between Use of Unconventional Therapies and Conventional Medical Services." JAMA 282, no. 7 (August 18, 1999): 651. http://dx.doi.org/10.1001/jama.282.7.651.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Bowling, Allen C., Ragaa Ibrahim, and Thomas M. Stewart. "Alternative Medicine and Multiple Sclerosis: An Objective Review from an American Perspective." International Journal of MS Care 2, no. 3 (October 1, 2000): 15–28. http://dx.doi.org/10.7224/1537-2073-2.3.15.

Full text
Abstract:
Abstract The use of complementary and alternative medicine (CAM), or unconventional medicine, may be challenging for health care providers in the United States. There are several definitions of CAM, and therapies that are considered alternative in one country may be conventional in other countries. Unconventional medical practices may be used instead of, or in addition to, conventional medical therapy. It may be difficult for people with multiple sclerosis (MS) to obtain reliable MS-relevant CAM information, and there may be conflicts between the values of patients and those of health care providers. These issues may create problems in the clinical decision-making process. The relevance to MS of some commonly used CAM therapies is discussed: herbal medicine, vitamins and minerals, marijuana, and a histamine and caffeine transdermal gel patch. Current information about the efficacy and safety of CAM therapies is extremely variable. Some therapies appear promising, others are unsafe or ineffective, and nearly all need to be studied further.
APA, Harvard, Vancouver, ISO, and other styles
37

Gianfaldoni, Serena, Georgi Tchernev, Jacopo Lotti, Uwe Wollina, Francesca Satolli, Miriam Rovesti, Katlein França, and Torello Lotti. "Unconventional Treatments for Vitiligo: Are They (Un) Satisfactory?" Open Access Macedonian Journal of Medical Sciences 6, no. 1 (January 21, 2018): 170–75. http://dx.doi.org/10.3889/oamjms.2018.038.

Full text
Abstract:
The authors show a brief overview of the vitiligo’s unconventional therapies. A part for well-documented effectiveness of L-phenylalanine, PGE2 and antioxidant agents in the treatment of vitiligo, for the other therapeutical approaches more investigations are needed.
APA, Harvard, Vancouver, ISO, and other styles
38

Gianfaldoni, Serena, Uwe Wollina, Michael Tirant, Georgi Tchernev, Jacopo Lotti, Francesca Satolli, Miriam Rovesti, Katlein França, and Torello Lotti. "Herbal Compounds for the Treatment of Vitiligo: A Review." Open Access Macedonian Journal of Medical Sciences 6, no. 1 (January 21, 2018): 203–7. http://dx.doi.org/10.3889/oamjms.2018.048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Münstedt, K., A. Entezami, A. Wartenberg, and U. Kullmer. "The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT)." European Journal of Cancer 36, no. 16 (October 2000): 2090–95. http://dx.doi.org/10.1016/s0959-8049(00)00194-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Robinson, E., H. Geva, T. Mashiach, G. Bar-Sela, and Z. Dashkowsky. "914 Characteristics and extent of unconventional therapies used by cancer patients." European Journal of Cancer Supplements 1, no. 5 (September 2003): S275. http://dx.doi.org/10.1016/s1359-6349(03)90941-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Menniti-Ippolito, F., R. Raschetti, and F. Chiarotti. "A national project for the evaluation of unconventional therapies in Italy." Focus on Alternative and Complementary Therapies 6, no. 1 (June 14, 2010): 86. http://dx.doi.org/10.1111/j.2042-7166.2001.tb02826.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Gray, Ross E., Margaret Fitch, and Marlene Greenberg. "A comparison of physician and patient perspectives on unconventional cancer therapies." Psycho-Oncology 7, no. 6 (November 1998): 445–52. http://dx.doi.org/10.1002/(sici)1099-1611(199811/12)7:6<445::aid-pon329>3.0.co;2-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Reuter-Rice, Karin E., and Bradley M. Peterson. "Conventional and Unconventional Lifesaving Therapies in an Adolescent With Amlodipine Ingestion." Critical Care Nurse 36, no. 4 (August 1, 2016): 64–69. http://dx.doi.org/10.4037/ccn2016524.

Full text
Abstract:
Amlodipine, a dihydropyridine calcium channel blocker, is commonly prescribed for the treatment of hypertension. Ingestion of an overdose leads to severe hypotension; if the hypotension is not treated, death may be imminent. Conventional and unconventional interventions were used to treat an adolescent who ingested a life-threatening dose of amlodipine. Severe hypotension resistant to conventional treatment with intralipids and hyperinsulinemia-euglycemia therapy led to the use of plasmapheresis and a pneumatic antishock garment as lifesaving measures. Plasmapheresis has been described in only one other case of severe amlodipine overdose, and the use of a pneumatic antishock garment has never been described in the management of a calcium channel blocker overdose. Because short-term use of a pneumatic antishock garment has associated risks, the critical care nurse’s anticipation of side effects and promotion of safe use of the garment were instrumental in the patient’s care and outcome. (Critical Care Nurse. 2016; 36[4]:64–69)
APA, Harvard, Vancouver, ISO, and other styles
44

Christou, Andrea and Lloyd Dini, Frank. "Unconventional cardiological therapies: indications for cardiac transplantation, an “unusual” case report." Cardiologia Ambulatoriale, no. 2 (September 23, 2019): 125–33. http://dx.doi.org/10.17473/1971-6818-2019-2-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Awouters, Marijke, Dirk Vanderschueren, and Leen Antonio. "Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?" Andrology 8, no. 6 (December 2, 2019): 1590–97. http://dx.doi.org/10.1111/andr.12725.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Resman-Targoff, Beth H. "Alternative Therapeutic Approaches to the Treatment of Arthritis." Journal of Pharmacy Practice 12, no. 4 (August 1999): 346–55. http://dx.doi.org/10.1177/089719009901200408.

Full text
Abstract:
Alternative therapies are widely used for the treatment of arthritis. Some examples of these are acupuncture/acupressure, animal venoms, copper bracelets, dimethyl sulfoxide, herbal products, magnets, and nutritional therapy. Many products used for alternative therapies are not regulated in the United States and can vary greatly in their content. They may contain toxic contaminants, induce allergic reactions, or interact with prescription medications. Much of the support for their use is based on testimonials and poorly controlled trials. The Office of Alternative Medicine was established under the National Institutes of Health to promote study and evaluation of unconventional therapies.
APA, Harvard, Vancouver, ISO, and other styles
47

Kelly, Kara M., Judith S. Jacobson, Deborah D. Kennedy, Steven M. Braudt, Mita Mallick, and Michael A. Weiner. "Use of Unconventional Therapies by Children With Cancer at an Urban Medical Center." Journal of Pediatric Hematology/Oncology 22, no. 5 (September 2000): 412–16. http://dx.doi.org/10.1097/00043426-200009000-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Romero-Rivera, Hector Rolando, Marticela Cabeza-Morales, Enrique Soto-Zarate, Guru Dutta Satyarthee, Huber Padilla-Zambrano, Andrei F. Joaquim, Andres M. Rubiano, Alfonso Pacheco Hernandez, Amit Agrawal, and Luis Rafael Moscote-Salazar. "Antioxidant therapies in traumatic brain injury: a review." Romanian Neurosurgery 31, no. 3 (September 1, 2017): 319–34. http://dx.doi.org/10.1515/romneu-2017-0053.

Full text
Abstract:
Abstract Oxidative stress constitute one of the commonest mechanism of the secondary injury contributing to neuronal death in traumatic brain injury cases. The oxidative stress induced secondary injury blockade may be considered as to be a good alternative to improve the outcome of traumatic brain injury (TBI) treatment. Due to absence of definitive therapy of traumatic brain injury has forced researcher to utilize unconventional therapies and its roles investigated in the improvement of management and outcome in recent year. Antioxidant therapies are proven effective in many preclinical studies and encouraging results and the role of antioxidant mediaction may act as further advancement in the traumatic brain injury management it may represent aonr of newer moadlaity in neurosurgical aramamentorium, this kind of therapy could be a good alternative or adjuct to the previously established neuroprotection agents in TBI.
APA, Harvard, Vancouver, ISO, and other styles
49

Giron, Fanny, Anna Pastó, Ennio Tasciotti, and Bincy P. Abraham. "Nanotechnology in the Treatment of Inflammatory Bowel Disease." Inflammatory Bowel Diseases 25, no. 12 (September 27, 2019): 1871–80. http://dx.doi.org/10.1093/ibd/izz205.

Full text
Abstract:
Nanotechnology is an emerging field where nanometer particles can be used to deliver medications directly to the area of inflammation thus avoiding drug-associated systemic side effects. Here we review conventional and unconventional therapies applied in the treatment of IBD underlying how the use of nanoparticles can improve their safety and efficacy.
APA, Harvard, Vancouver, ISO, and other styles
50

Banh, Hoan Linh. "Unconventional Treatment Options in Severe Asthma: An Overivew." Journal of Pharmacy & Pharmaceutical Sciences 14, no. 3 (October 7, 2011): 387. http://dx.doi.org/10.18433/j37s36.

Full text
Abstract:
In Canada, asthma is the leading cause of admission in hospital. About of 80% of the death from asthma is preventable. Severe asthma is defined as a patient with persistent symptoms despite the use of adequate controller therapy, including multiple courses of oral glucocorticosteroids. However, about 10% of patients with severe asthma remain poorly controlled despite optimal treatment and these patients have the greatest morbidity and mortality. The management of refractory severe asthma remains extremely challenging. For patients with refractory severe asthma, the adjunct therapies recommended by national guidelines only included oral glucocorticosteroid and anti-IgE antibody (omalizumab) therapy. Currently, there is limited published literature on the unconventional treatments of refractory severe asthma. The objective of this review article is to provide an updated therapeutic overview of unconventional treatment options for refractory severe asthma. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography